INTRODUCTION: We investigated the efficacy and necessity of repeat transurethral resection (Re-TUR) in T1 bladder cancer. PATIENTS AND METHODS: From September 2004 to September 2009, 62 patients with pathologically confirmed T1 bladder tumours were investigated. Re-TUR was routinely performed within 3-6 weeks following the initial resection. The pathological results of the Re-TUR were reviewed, and the risk of recurrence was investigated. RESULTS: Of the 62 patients who underwent Re-TUR, 22 had a residual tumour pathologically. Visible residual tumours were detected in 9 patients (14.5%). The risk of having a residual tumour was directly correlated with the diameter of the initial tumour in T1 tumours (p = 0.007). CONCLUSIONS: Upstaging to T2 of the disease led to radical cystectomy in 11.29% of the patients in our series. Re-TUR should be routinely performed on all patients, especially on patients with high-grade tumours and with tumour diameters greater than 3 cm in T1 bladder cancer.
INTRODUCTION: We investigated the efficacy and necessity of repeat transurethral resection (Re-TUR) in T1 bladder cancer. PATIENTS AND METHODS: From September 2004 to September 2009, 62 patients with pathologically confirmed T1 bladder tumours were investigated. Re-TUR was routinely performed within 3-6 weeks following the initial resection. The pathological results of the Re-TUR were reviewed, and the risk of recurrence was investigated. RESULTS: Of the 62 patients who underwent Re-TUR, 22 had a residual tumour pathologically. Visible residual tumours were detected in 9 patients (14.5%). The risk of having a residual tumour was directly correlated with the diameter of the initial tumour in T1 tumours (p = 0.007). CONCLUSIONS: Upstaging to T2 of the disease led to radical cystectomy in 11.29% of the patients in our series. Re-TUR should be routinely performed on all patients, especially on patients with high-grade tumours and with tumour diameters greater than 3 cm in T1 bladder cancer.
Authors: François Audenet; Caitlyn Retinger; Christine Chien; Nicole E Benfante; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni Journal: Urol Oncol Date: 2017-07-06 Impact factor: 3.498
Authors: Ji Sung Shim; Hoon Choi; Tae Il Noh; Jong Hyun Tae; Sung Goo Yoon; Seok Ho Kang; Jae Hyun Bae; Hong Seok Park; Jae Young Park Journal: Korean J Urol Date: 2015-05-28
Authors: Anna Katarzyna Czech; Katarzyna Gronostaj; Jakub Frydrych; Jakub Fronczek; Mikołaj Przydacz; Tomasz Wiatr; Łukasz Curyło; Przemysław Dudek; Jerzy Gąsowski; Piotr L Chłosta Journal: Cent European J Urol Date: 2019-09-16